NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bios Partners

Bios Partners

Fort Worth, Texasbiospartners.com

Overview

Bios Partners is a venture capital firm focused on identifying and investing in advanced biotech opportunities in overlooked and under-invested markets across the U.S. The firm aims to disrupt geographic favoritism in venture capital by supporting compelling scientific ventures in the Central U.S. that are often undervalued. Bios Partners is driven by a mission to cultivate these companies and bring innovative biotech solutions to market.

Year Founded

2014

Portfolio Companies

9

Investments

Bios Partners investments
CompanyDateStageLead
i-Lumen ScientificDec 2025Series BLead
Bobcat BioFeb 2025Series A ExtensionCo-investor
ONL TherapeuticsSep 2024Series DCo-investor
Bobcat BioJan 2024Series BCo-investor
Renibus TherapeuticsSep 2023Series BLead

Key People

Aaron Fletcher

Founder General Partner

Stella Robertson

Co-Founder, Partner

Amanda de la Garza

Partner

John Fucci

Partner

Timothy Van Treuren

Principal Of New Investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersFort Worth, Texas
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.